Jazz Pharmaceuticals (JAZZ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 69 | 19.6% |
| Current Price ( 9/28 4:00PM EDT) | $131.03 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 3,762.9 | |||
| Sales Growth Forecast | 8.3% | |||
| Net Profit Margin | 33.4% | |||
| Projected Shares Outstanding | 70.00 | |||
| EPS - Five year Forecast | $26.76 | |||
| Average P/E Ratio | 12.0 | |||
| Projected Average Price | $321.13 | |||
| Price Appreciation (Annualized) | 19.6% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 19.6% | |||
| Quality | ||||
| Financial Strength | 73 | 18.3 | ||
| EPS Stability | 73 | 18.2 | ||
| Industry Sales Growth Rate | 15.0% | 6.9 | ||
| Industry Net Profit Margin | 30.0% | 13.9 | ||
| Calculated Quality Rating | 57.2 | |||
| Fool CAPS | ||||
Total Players
285
Outperforms
67
Underperforms
All-Stars (64)
44
Outperforms (69%)
20
Underperforms
|
||||
| Fundamental Data Updated: 09/01/2023 | ||||